Regarding systemic treatment, although the epithelial component of most phyllodes tumors contains estrogen receptors (58%) and/or progesterone receptors (75%), endocrine therapy has no proven role in the treatment of these tumors. The gene discussed is ESR1; the disease is phyllodes tumor.